Pathological Complete Response Clinical Trials

17 clinical trials for Pathological Complete Response across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy — RECRUITING · NA
• Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
• Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy — RECRUITING
• Omission of ALND in Breast Cancer Patients With Axillary pCR — RECRUITING · NA
• Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer — NOT_YET_RECRUITING
• Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning — ACTIVE_NOT_RECRUITING
• Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer — NOT_YET_RECRUITING
• Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features — COMPLETED
• Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade — COMPLETED
• Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy — OTHER
• Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer — SUSPENDED · PHASE3
• Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial — OTHER · PHASE2
• Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy — OTHER · PHASE2
• RISAS Procedure in Node Positive Breast Cancer Following NAC — COMPLETED · NA
• DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer — COMPLETED · PHASE2
• Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy — OTHER · PHASE2

Refine this search